 ClearPoint Neuro, Inc. CLPT the Company today provided an update with respect to the COVID-19 pandemic and announced preliminary financial results for the quarter ended March 31, 2020. Given the unprecedented events resulting from the COVID-19 pandemic, we are providing this update to patients, our hospital customers, our employees and our investors, to inform how the pandemic is affecting our business, and to comment on what we believe continues to be the strength and resiliency of our Company, commented Joe Burnett, ClearPoint Neuros President and CEO. 